Bio-Techne
TECH
HK$417.44
Share price
2.11%
Change (1 day)
-25.39%
Change (1 year)
Categories
Bio-Techne Corporation is an American holding company for biotechnology and clinical diagnostic brands. The company's brands portfolio includes R&D Systems, Novus Biologicals, Tocris Bioscience, ProteinSimple, Exosome Diagnostics, BiosPacific, Cliniqa, Advanced Cell Diagnostics, RNA Medical, Bionostics and BostonBiochem.
Market capitalization of Bio-Techne (TECH)
Market cap: HK$65.44 Billion
As of July 2025 Bio-Techne has a market cap of HK$65.44 Billion. This makes Bio-Techne the world's 2114th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.
Market cap history of Bio-Techne from 1996 to 2025
End of year Market Cap
| Year | Marketcap | Change |
|---|---|---|
| 2025 | HK$65.44 B | -27.31% |
| 2024 | HK$90.02 B | -5.54% |
| 2023 | HK$95.30 B | -6.24% |
| 2022 | HK$101.64 B | -35.88% |
| 2021 | HK$158.51 B | 66.78% |
| 2020 | HK$95.04 B | 45.23% |
| 2019 | HK$65.44 B | 53.04% |
| 2018 | HK$42.76 B | 12.78% |
| 2017 | HK$37.91 B | 27.45% |
| 2016 | HK$29.75 B | 14.68% |
| 2015 | HK$25.94 B | -2.46% |
| 2014 | HK$26.59 B | -1.82% |
| 2013 | HK$27.08 B | 38.8% |
| 2012 | HK$19.51 B | -0.51% |
| 2011 | HK$19.61 B | 3.41% |
| 2010 | HK$18.97 B | -4.23% |
| 2009 | HK$19.80 B | 5.97% |
| 2008 | HK$18.69 B | -7.43% |
| 2007 | HK$20.19 B | 18.86% |
| 2006 | HK$16.98 B | 0.48% |
| 2005 | HK$16.90 B | 35.36% |
| 2004 | HK$12.49 B | 3.77% |
| 2003 | HK$12.03 B | 30.09% |
| 2002 | HK$9.25 B | -22.43% |
| 2001 | HK$11.92 B | 2.3% |
| 2000 | HK$11.65 B | 34.92% |
| 1999 | HK$8.64 B | 163.22% |
| 1998 | HK$3.28 B | 27.96% |
| 1997 | HK$2.56 B | 35.02% |
| 1996 | HK$1.90 B |
End of Day market cap according to different sources
On Jul 1st, 2025 the market cap of Bio-Techne was reported to be:
HK$64.08 Billion
HK$64.08 Billion
Market capitalization for similar companies or competitors
| Name | Marketcap | Market cap differencediff. | Country |
|---|---|---|---|
 Thermo Fisher Scientific TMO | HK$1.267 T | 1,836.89% | 🇺🇸 USA |
 Bio-Rad Laboratories BIO | HK$53.02 B | -18.97% | 🇺🇸 USA |
 Becton Dickinson BDX | HK$398.72 B | 509.29% | 🇺🇸 USA |
 Danaher DHR | HK$1.137 T | 1,637.83% | 🇺🇸 USA |
 Qiagen QGEN | HK$82.64 B | 26.29% | 🇳🇱 Netherlands |
 General Electric GE | HK$2.046 T | 3,027.46% | 🇺🇸 USA |
 Enzo Biochem ENZB | HK$0.28 B | -99.57% | 🇺🇸 USA |